Trabecular thickening on mammography post-COVID vaccine and RSV vaccine: Case report

Ipsilateral axillary adenopathy post-COVID mRNA vaccine has been widely reported and guidelines for management have been established. Isolated changes of axillary tail trabecular thickening without associated adenopathy in the breast present a diagnostic dilemma and no official guidelines have thus...

Full description

Bibliographic Details
Published in:	Radiology Case Reports
Main Authors:	Adam Siegel, MD, Richard Adam, BS, Rhianna Rubner, MD, Henrietta Bains, BS, Richard Ha, MD, Takouhie Maldjian, MD
Format:	Article
Language:	English
Published:	Elsevier 2024-09-01
Subjects:	COVID-19 vaccine RSV vaccine Mammography Trabecular thickening Axillary tail breast edema
Online Access:	http://www.sciencedirect.com/science/article/pii/S1930043324004412

Similar Items

Preventing RSV Infection in Children: Current Passive Immunizations and Vaccine Development
by: Pius I. Babawale, et al.
Published: (2025-01-01)

Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysisResearch in context
by: Daira Trusinska, et al.
Published: (2025-06-01)

Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine
by: Alexander Domnich, et al.
Published: (2025-01-01)

Polymyalgia rheumatica following respiratory syncytial virus (RSV) vaccination
by: Mohamad El Labban, et al.
Published: (2024-06-01)

Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
by: Ariel Isaacs, et al.
Published: (2021-01-01)

Brief communication: predictors of RSV vaccine uptake among older adults in South Dakota
by: Filip Viskupič, et al.
Published: (2025-04-01)

Respiratory Syncytial Virus (RSV) Hospitalizations in the Elderly in a Tertiary Care Hospital in Southern Italy as a Useful Proxy for Targeting Vaccine Preventive Strategies
by: Francesca Centrone, et al.
Published: (2024-05-01)

Adult RSV Vaccination: What Is the Role of RSV Subgroup in Disease Prevention?
by: S. Elizabeth Williams, et al.
Published: (2026-05-01)

RSV awareness, risk perception, causes, and terms: Comment
by: Somsri Wiwanitkit, et al.
Published: (2023-12-01)

Immunopathogenesis associated with formaldehyde-inactivated RSV vaccine in preclinical and clinical studies
by: Abenaya Muralidharan, et al.
Published: (2017-04-01)

Maternal RSV vaccine development. Where to from here?
by: Ahinsa Gunatilaka, et al.
Published: (2021-11-01)

Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection
by: Mariana Guerra-Maupome, et al.
Published: (2019-01-01)

Lessons learned from COVID-19 vaccine acceptance among pregnant and lactating women from two districts in Kenya to inform demand generation efforts for future maternal RSV vaccines
by: Rupali J. Limaye, et al.
Published: (2024-03-01)

Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine
by: Harrison C. Bergeron, et al.
Published: (2023-06-01)

Prospective Attitudes towards Respiratory Syncytial Virus (RSV) Vaccination: Validation of a Survey Instrument among Young Females in Jordan Pending Vaccine Authorization
by: Tleen Kherfan, et al.
Published: (2023-08-01)

Exploring parental perspectives: Maternal RSV vaccination versus infant RSV monoclonal antibody
by: Bryony Treston, et al.
Published: (2024-12-01)

Respiratory Syncytial Virus Vaccination Acceptance: The Importance of Asking “Why?”
by: Molly Zeme, BA, et al.
Published: (2025-09-01)

Barriers and facilitators of respiratory syncytial virus (RSV) vaccine confidence among a community-based sample of predominantly Latino older adults in San Francisco
by: Fernanda Amaya, et al.
Published: (2026-06-01)

Challenges and Limitations of Current RSV Prevention Strategies in Infants and Young Children: A Narrative Review
by: Nicola Principi, et al.
Published: (2025-07-01)

Correlative outcomes of maternal immunization against RSV in cotton rats
by: Jorge C. G. Blanco, et al.
Published: (2022-12-01)

Safety and immunogenicity of an mRNA-based RSV vaccine in seropositive children aged 12–59 months
by: Sabine Schnyder Ghamloush, et al.
Published: (2025-12-01)

RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
by: Harrison C. Bergeron, et al.
Published: (2022-10-01)

RSV Disease Threat and Innovative Prevention Methods in Health Protection: A Review
by: Paulina Dąbrowska, et al.
Published: (2024-02-01)

All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design?
by: Sofie Schaerlaekens, et al.
Published: (2024-01-01)

Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
by: Carlotta Biagi, et al.
Published: (2020-11-01)

Prevention of Lower Respiratory Tract Diseases caused by RSV in Infants in Poland: A Review of Current Recommendations
by: Gabriela Zofia Mierzwa, et al.
Published: (2024-12-01)

A bivalent mRNA vaccine against RSV infection in rodent models
by: Juan Liu, et al.
Published: (2025-03-01)

RSV disease in infants and young children: Can we see a brighter future?
by: Eugenio Baraldi, et al.
Published: (2022-11-01)

Immunogenicity, safety and reactogenicity of Ad26.RSV.preF/RSV preF protein vaccine in adults aged 60 to 75 years: A comparison of phase 2b and phase 3 clinical trial material
by: Archana Jastorff, et al.
Published: (2024-12-01)

RSV Vaccine Based on Rhabdoviral Vector Protects after Single Immunization
by: Sarah Wilmschen, et al.
Published: (2019-07-01)

Evaluating the efficacy, safety, and immunogenicity of FDA-approved RSV vaccines: a systematic review of Arexvy, Abrysvo, and mResvia
by: Thamir A. Alandijany, et al.
Published: (2025-08-01)

Highly Effective mRNA-LNP Vaccine Against Respiratory Syncytial Virus (RSV) in Multiple Models
by: Huarong Bai, et al.
Published: (2025-06-01)

An Optimized FI-RSV Vaccine Effectively Protects Cotton Rats and BALB/c Mice without Causing Enhanced Respiratory Disease
by: Min Lin, et al.
Published: (2022-09-01)

Editorial: How RSV outsmarts the host
by: Stephania A. Cormier, et al.
Published: (2024-12-01)

Boosting RSV Immunization Uptake in The Netherlands: (Expectant) Mothers and Healthcare Professionals’ Insights on Different Strategies
by: Lisanne van Leeuwen, et al.
Published: (2025-10-01)

Maternal vaccination against RSV can substantially reduce childhood mortality in low-income and middle-income countries: A mathematical modeling study
by: Joukje E. Willemsen, et al.
Published: (2023-12-01)

A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults
by: Antonios O. Aliprantis, et al.
Published: (2021-05-01)

Post-marketing safety monitoring of RSV vaccines: A real-world study based on the Vaccine Adverse Event Reporting System (VAERS)
by: Zhuocheng Bao, et al.
Published: (2025-12-01)

Immunogenicity and safety of Ad26.RSV.preF/RSV preF protein vaccine at predicted intermediate- and end-of-shelf-life as an evaluation of potency throughout shelf life
by: Tessa Hosman, et al.
Published: (2024-12-01)

Neonatal priming and infancy boosting with a novel respiratory syncytial virus vaccine induces protective immune responses without concomitant respiratory disease upon RSV challenge
by: Shuren Zhang, et al.
Published: (2020-03-01)